knowledge -WSS

knowledge

author：hotspot 2025-10-01 02:13:24 - browse：11633

Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

knowledge

WSS

PBM reform efforts get punted in Congress

Cherokee Nation medical school graduates its first class

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Dario to buy mental health app maker Twill in cash and stock deal

focus

knowledge

explore

In age of alternative facts, a scholarly course on calling out crap

HHS suspends federal funding for EcoHealth Alliance

The cancer drug shortage isn’t new — and neither are the solutions

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Supreme Court strikes down use of affirmative action

6 phony surgeries that take placebo to the extreme

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The United States must get value

Virginia high school admissions case could be legal follow

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

focus

Boston hospital trains restaurant workers on naloxone for overdoses

STAT reporters are Pulitzer Prize finalists for investigative reporting

The United States must get value

Why palliative psychiatry is worth discussing

The White House hikes tariffs on plastic syringes made in China

6 phony surgeries that take placebo to the extreme

hotspot

leisure time

knowledge

explore